These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 30483804)
1. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway. Zhang X; Shao J; Li X; Cui L; Tan Z Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804 [TBL] [Abstract][Full Text] [Related]
2. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498 [TBL] [Abstract][Full Text] [Related]
3. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors. Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406 [TBL] [Abstract][Full Text] [Related]
4. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma. Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923 [TBL] [Abstract][Full Text] [Related]
5. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma. Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT Cells; 2020 Mar; 9(3):. PubMed ID: 32197467 [TBL] [Abstract][Full Text] [Related]
6. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells. You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147 [TBL] [Abstract][Full Text] [Related]
7. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism]. Lin F; Yan W; Wen T; Wu GY Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [TBL] [Abstract][Full Text] [Related]
9. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772 [TBL] [Abstract][Full Text] [Related]
10. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK. Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788 [TBL] [Abstract][Full Text] [Related]
11. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993 [TBL] [Abstract][Full Text] [Related]
12. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling. Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702 [TBL] [Abstract][Full Text] [Related]
13. A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways. Liu Y; Qi Y; Bai ZH; Ni CX; Ren QH; Xu WH; Xu J; Hu HG; Qiu L; Li JZ; He ZG; Zhang JP Acta Pharmacol Sin; 2017 Jan; 38(1):120-132. PubMed ID: 27773936 [TBL] [Abstract][Full Text] [Related]
14. EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis. Liu X; Gao X; Yang Y; Yang D; Guo Q; Li L; Liu S; Cong W; Lu S; Hou L; Wang B; Li N Apoptosis; 2024 Aug; 29(7-8):1161-1184. PubMed ID: 38743191 [TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957 [TBL] [Abstract][Full Text] [Related]
16. PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation. Gedaly R; Galuppo R; Musgrave Y; Angulo P; Hundley J; Shah M; Daily MF; Chen C; Cohen DA; Spear BT; Evers BM J Surg Res; 2013 Nov; 185(1):225-30. PubMed ID: 23769634 [TBL] [Abstract][Full Text] [Related]
17. Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT. Zhou HH; Chen L; Liang HF; Li GZ; Zhang BX; Chen XP Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110775 [TBL] [Abstract][Full Text] [Related]
18. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway. Gen Y; Yasui K; Nishikawa T; Yoshikawa T Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069 [TBL] [Abstract][Full Text] [Related]
19. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533 [TBL] [Abstract][Full Text] [Related]